What does CUSIP 87164F105 represent in this 13F holders report?

CUSIP 87164F105 is the security identifier for SNDX - Syndax Pharmaceuticals Inc - Common Stock used to aggregate holder disclosures.

How many institutions held SNDX - Syndax Pharmaceuticals Inc - Common Stock in Q3 2022?

136 institutional investors reported SNDX - Syndax Pharmaceuticals Inc - Common Stock for Q3 2022. Use the holders table for investor-level position and value details.

Syndax Pharmaceuticals Inc - Common Stock (SNDX)

CUSIP: 87164F105

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Stock
Shares outstanding: 88,260,257
Total 13F shares: 59,986,014
Share change: +3,679,422
Total reported value: $1,441,473,166
Put/Call ratio: 8.9%
Price per share: $24.03
Number of holders: 136
Value change: +$97,845,580
Number of buys: 86
Number of sells: 39

Quarterly Holders Quick Answers

What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 87164F105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Avidity Partners Management LP	13F	Company	6.2%	5,450,000	$104,858,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	4.3%	3,795,909	$73,032,000	—	30 Jun 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.6%	3,206,866	$61,699,000	—	30 Jun 2022	13F
Frazier Life Sciences Management, L.P.	13F	Company	3.6%	3,195,403	$61,480,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	3.2%	2,780,903	$53,504,000	—	30 Jun 2022	13F
Nantahala Capital Management, LLC	13F	Company	3%	2,663,087	$51,238,000	—	30 Jun 2022	13F
Kynam Capital Management, LP	13F	Company	2.8%	2,512,240	$48,335,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	2.8%	2,435,517	$46,859,000	—	30 Jun 2022	13F
BVF INC/IL	13F	Company	2.7%	2,356,934	$45,347,000	—	30 Jun 2022	13F
ORBIMED ADVISORS LLC	13F	Company	2.6%	2,323,300	$44,700,000	—	30 Jun 2022	13F
Avoro Capital Advisors LLC	13F	Company	2.5%	2,222,222	$42,756,000	—	30 Jun 2022	13F
CITADEL ADVISORS LLC	13F	Company	2%	1,729,052	$33,267,000	—	30 Jun 2022	13F
683 Capital Management, LLC	13F	Company	1.8%	1,581,653	$30,431,000	—	30 Jun 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.4%	1,237,300	$23,806,000	—	30 Jun 2022	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	1.3%	1,139,329	$21,921,000	—	30 Jun 2022	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.3%	1,111,111	$21,378,000	—	30 Jun 2022	13F
Aisling Capital Management LP	13F	Company	1.2%	1,025,000	$19,721,000	—	30 Jun 2022	13F
Eversept Partners, LP	13F	Company	1.1%	994,362	$19,131,525	—	30 Jun 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.1%	961,106	$18,490,000	—	30 Jun 2022	13F
HealthCor Management, L.P.	13F	Company	1%	923,400	$17,766,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1%	907,856	$17,467,000	—	30 Jun 2022	13F
Paradigm Biocapital Advisors LP	13F	Company	0.99%	876,156	$16,857,000	—	30 Jun 2022	13F
Palo Alto Investors LP	13F	Company	0.69%	612,600	$11,786,000	—	30 Jun 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.67%	594,302	$11,434,000	—	30 Jun 2022	13F
PFM Health Sciences, LP	13F	Company	0.66%	580,768	$11,174,000	—	30 Jun 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.62%	546,239	$10,510,000	—	30 Jun 2022	13F
Phoenix Financial Ltd.	13F	Company	0.6%	525,856	$10,117,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	0.55%	487,913	$9,387,000	—	30 Jun 2022	13F
CITIGROUP INC	13F	Company	0.53%	463,965	$8,927,000	—	30 Jun 2022	13F
Sofinnova Investments, Inc.	13F	Company	0.47%	413,428	$7,954,000	—	30 Jun 2022	13F
DAFNA Capital Management LLC	13F	Company	0.42%	370,987	$7,138,000	—	30 Jun 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.4%	356,905	$6,867,000	—	30 Jun 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.4%	352,852	$6,789,000	—	30 Jun 2022	13F
UBS Group AG	13F	Company	0.36%	316,675	$6,092,000	—	30 Jun 2022	13F
LORD, ABBETT & CO. LLC	13F	Company	0.36%	314,914	$6,059,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	0.33%	291,664	$5,611,000	—	30 Jun 2022	13F
Ghost Tree Capital, LLC	13F	Company	0.25%	225,000	$4,329,000	—	30 Jun 2022	13F
Assenagon Asset Management S.A.	13F	Company	0.24%	210,744	$4,055,000	—	30 Jun 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.23%	206,818	$3,979,000	—	30 Jun 2022	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.23%	205,003	$3,944,000	—	30 Jun 2022	13F
MACQUARIE GROUP LTD	13F	Company	0.21%	180,991	$3,482,000	—	30 Jun 2022	13F
Bank of New York Mellon Corp	13F	Company	0.19%	167,187	$3,217,000	—	30 Jun 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.19%	165,842	$3,191,000	—	30 Jun 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.14%	126,191	$2,428,000	—	30 Jun 2022	13F
FMR LLC	13F	Company	0.14%	125,656	$2,418,000	—	30 Jun 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	0.13%	110,729	$2,130,000	—	30 Jun 2022	13F
Allianz Asset Management GmbH	13F	Company	0.12%	108,655	$2,091,000	—	30 Jun 2022	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	107,852	$2,075,000	—	30 Jun 2022	13F
Swiss National Bank	13F	Company	0.12%	105,200	$2,024,000	—	30 Jun 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.11%	94,474	$1,818,000	—	30 Jun 2022	13F

Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q3 2022

As of 30 Sep 2022, Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by 136 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,986,014 shares. The largest 10 holders included Avidity Partners Management LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Frazier Life Sciences Management, L.P., VANGUARD GROUP INC, STATE STREET CORP, Kynam Capital Management, LP, Avoro Capital Advisors LLC, ORBIMED ADVISORS LLC, and BVF INC/IL. This page lists 136 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

116

Q3 2022 holders

136

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.